EP2346495
Lyfjasamsetning 514
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
5.10.2009EP published:
20.7.2016EP application number:
09740728.2
EP translation filed:
12.9.2016Grant published:
15.10.2016EPO information:
European Patent Register
Max expiry date:
4.10.2029Expiry date:
4.10.2026Next due date:
31.10.2026
Title:
PHARMACEUTICAL FORMULATION 514
Timeline
Today
5.10.2009EP application
20.7.2016EP Publication
12.9.2016Translation submitted
15.10.2016Registration published
4.10.2026Expires
Owner
Name:
Kudos Pharmaceuticals LimitedAddress:
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, GB
Inventor
Name:
BECHTOLD, Michael, KarlAddress:
Ludwighafen, DE
Name:
PACKHAEUSER, Claudia, BettinaAddress:
Ludwighafen, DE
Name:
CAHILL, Julie, KayAddress:
Macclesfield Cheshire SK10 4TG, GB
Name:
FASTNACHT, Katja, MarenAddress:
Ludwighafen, DE
Name:
LIEPOLD, Bernd, HaraldAddress:
Ludwighafen, DE
Name:
LENNON, Kieran, JamesAddress:
Macclesfield Cheshire SK10 4TG, GB
Name:
STEITZ, BenediktAddress:
Ludwighafen, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
103347 PDate:
7.10.2008Country:
US
Supplementary protection
SPC number:
SPC242
Classification
Categories:
A61K 31/502, A61K 47/32
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 29.9.2016
Expires: 4.10.2017
Payer: Árnason Faktor
Number: 9
Paid: 11.9.2017
Expires: 4.10.2018
Payer: Árnason Faktor
Number: 10
Paid: 6.9.2018
Expires: 4.10.2019
Payer: Árnason Faktor
Number: 11
Paid: 9.9.2019
Expires: 4.10.2020
Payer: Árnason Faktor
Number: 12
Paid: 9.9.2020
Expires: 4.10.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.9.2021
Expires: 4.10.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 7.9.2022
Expires: 4.10.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 25.9.2023
Expires: 4.10.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 17.9.2024
Expires: 4.10.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 2.10.2025
Expires: 4.10.2026
Payer: Árnason Faktor ehf.